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Abstract
Pakistan harbors high disease burden of gastro-enteric infections with majority of these caused by rotavirus. Unfortunately,
lack of proper surveillance programs and laboratory facilities have resulted in scarcity of available data on rotavirus
associated disease burden and epidemiological information in the country. We investigated 1306 stool samples collected
over two years (2008–2009) from hospitalized children under 5 years of age for the presence of rotavirus strains and its
genotypic diversity in Lahore. The prevalence rate during 2008 and 2009 was found to be 34% (n = 447 out of 1306). No
significant difference was found between different age groups positive for rotavirus (p.0.05). A subset of EIA positive
samples was further screened for rotavirus RNA through RT-PCR and 44 (49.43%) samples, out of total 89 EIA positive
samples, were found positive. G and P type prevalence was found as follows: G1P [4] = 3(6.81%); G1P [6] = 9(20.45%); G1P
[8] = 1(2.27%); G2P [4] = 21(47.72%); G2P [8] = 1(2.27%); G9P [4] = 1(2.27%); G9P [6] = 1(2.27%) and G9P [8] = 7(15.90%).
Phylogenetic analysis revealed that the VP7 and VP4 sequences clustered closely with the previously detected strains in the
country as well as Belgian rotaviruses. Antigenic characterization was performed by analyzing major epitopes in the
immunodominant VP7 and VP4 gene segments. Although the neutralization conferring motifs were found variable between
the Pakistani strains and the two recommended vaccines strains (RotarixTM and RotaTeqTM), we validate the use of rotavirus
vaccine in Pakistan based on the proven and recognized vaccine efficacy across the globe. Our findings constitute the first
report on rotavirus’ genotype diversity, their phylogenetic relatedness and epidemiology during the pre-vaccination era in
Lahore, Pakistan and support the immediate introduction of rotavirus vaccine in the routine immunization program of the
country.
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Introduction
Diarrheal infections are considered as a significant cause of
infant and childhood morbidity and mortality in both developing
as well as developed countries [1]. Most of these infections have a
viral etiology principally rotaviruses that alone account for
approximately 527,000 (475000–580000) deaths per annum
among children less than 5 years of age [2,3]. Globally, more
than 2 million children are hospitalized every year for rotavirus
infection and 90% of rotavirus associated mortalities occur in
Africa and Asia [4,5]. Rotaviruses have been classified into seven
heterogenic groups (A to G) based on their genetic and antigenic
properties. Group A rotaviruses are the most important and
frequently detected viruses among the three groups A, B and C
that infect humans [6]. The virus belongs to the family reoviridae
with triple-coated icosahedral virion particle, enclosed within is the
11 segmented double stranded RNA genome. The triple layered
capsid consists of 2 proteins in the outer shell (VP7 and VP4), the
intermediate layer constitutes VP6 while VP2 forms the inner
layer enclosing two proteins VP1 and VP3. Based on VP6 capsid
gene, the virus has been classified into seven major genogroups
while VP7 and VP4 are the basis of a binary-system for further
classifying the genogroup A viruses into 27 G- and 35 P- genotypes
respectively [7]. Globally, the most important types causing
majority of infections are G1P [8], G2P [4], G3P [8], G4P [8] and
G9P [8] [8,9]. However, significant diversity of rotavirus
genotypes have emerged with several novel combinations due to
accumulation of point mutations, genome re-assortments or
zoonotic transmission of animal strains resulting in the introduc-
tion of new antigenic variants [10,11].
Rotavirus strain identification is considered as the key
component of epidemiological surveys, disease distribution,
genotype prevalence studies, vaccine administration and efficacy
monitoring programs. Many past studies have highlighted the
significance of continued monitoring of circulating rotavirus
strains in order to maintain sufficient population immunity [12].
In Pakistan, there is no well-developed surveillance system for
rotavirus strain identification although country’s Ministry of
PLOS ONE | www.plosone.org 1 June 2013 | Volume 8 | Issue 6 | e67998
Health has initiated a hospital based surveillance network to
serologically test the stool samples from children presented with
gastroenteritis at central district hospitals in 3 major cities; Karachi
(Sindh province), Lahore and Rawalpindi (Punjab province).
These sentinel sites perform ELISA for the diagnosis of rotavirus
infection without any further analysis for viral genotype identifi-
cation. This study is in continuation to our previous work where
we identified an emerging rotavirus genotype G12 in two children
admitted to a hospital in Rawalpindi [13]. To further explore the
epidemiology and genotypic diversity of rotavirus in Pakistan, here
we report the findings of rotavirus subtypes detected in children
hospitalized, due to severe dehydrating diarrhea, at Children’s
Hospital Lahore.
Materials and Methods
Samples from hospitalized children suspected of rotavirus
gastroenteritis were collected as per World Health Organization’s
standard case definitions that describe a suspected case as a child
,5 years of age, admitted to a designated sentinel hospital for
treatment of gastroenteritis while a confirmed case is a suspected
case in whose stool the presence of rotavirus is demonstrated by
means of an enzyme immunoassay. The study concept and design
was approved through the Pakistan’s National Institute of Health
Internal Review Board. The samples were collected after informed
and written consent from the patient’s parents/guardians.
A total of 1306 stool samples were collected from hospitalized
patients at ‘The Children’s Hospital’ Lahore during January 2008
to December 2009. Majority of these samples were collected from
children below than 5 years of age who were hospitalized with
suspected rotavirus gastroenteritis. The collected stool samples
were processed for the detection and confirmation of Rotavirus
antigen. ELISA test was performed using the ProSpecTTM
Rotavirus Microplate Assay (Oxoid Ltd., Basingstoke Hants,
UK) as per World Health Organization’s recommendations
(http://whqlibdoc.who.int/publications/2011/
9789241502641_eng.pdf).
A subset (20%) of EIA positive samples were transported to
Department of Virology, National Institute of Health, Islamabad
for rotavirus RNA detection through RT-PCR and further
genotype determination on the basis of VP7 and VP4 gene
segments using the protocol as described by Gouvea et al 1990
[14] and Gentsch et al 1992 [15] respectively. Amplified products
from round 1 PCR reactions were purified using QIAquick PCR
purification kit (Qiagen, Germany) and were directly sequenced
for VP7 and VP4 genes using the Big dye terminator sequencing
kit v3.0 by automated Genetic analyzer ABI 3130xl (Applied
Biosystems).
Phylogenetic analyses of VP7 and VP4 sequences were
performed in comparison to the strains belonging to different
geographical regions as retrieved from GenBank. Evolutionary
tree and distances (number of base substitutions per site) were
generated by Neighbor Joining method with Kimura-2 parameter
using MEGA 4.0 (http://megasoftware.net/). The percentage of
replicate trees in which the associated taxa clustered together in
the bootstrap test (1000 replicates) is shown next to the branches.
The GenBank accession numbers, country, year of sample
collection and respective genotype information has been given
where available. The VP7 sequences obtained in this study have
been submitted to GenBank under the accession numbers
KC896141-KC896157 and the VP4 sequences under accession
numbers KC896127-KC896140.
Results
Prevalence, Epidemiology and RVA-Genotypes
Screening of total 1306 samples collected during two years
period (2008–2009) for the presence of rotavirus antigen yielded
447 (34.22%) samples positive for group A major inner capsid
protein (VP6 antigen) common to all known rotavirus genotypes.
The prevalence rates during 2008 and 2009 were 34.12% (n= 243
out of 712) and 34.34% (204 out of 594) respectively. No
significant difference (P.0.05) was found between different age
groups positive for rotavirus through ELISA; however, high
infection rate was observed among children between 12–17 and
24–59 months during 2008 and 2009 respectively. The rotavirus
positive cases appeared to occur throughout the year with peaks
during January to April and July to September (Figure 1a and 1b).
A subset of EIA positive samples, based on availability, was
further screened for the presence of rotavirus RNA through RT-
PCR. Out of total 89 EIA positive samples available from archived
stock kept at -80uC, 44 (49.43%) samples were found positive for
rotavirus through PCR. G and P types were found with the
prevalence as G1P [4] = 3(6.81%); G1P [6] = 9(20.45%); G1P
[8] = 1(2.27%); G2P [4] = 21(47.72%); G2P [8] = 1(2.27%); G9P
[4] = 1(2.27%); G9P [6] = 1(2.27%) and G9P [8] = 7(15.90%).
Phylogenetic Analysis Based on RVA-VP7 and -VP4 Gene
Segments
The genetic sequence of 18 viruses included in this study was
determined for the VP7 gene. These samples were randomly
selected on the basis of sample quantity and resource limitations
which showed that all viruses are highly identical (99–100%) to
each other within their respective genotypes; G1, G2 and G9. The
G1 strains shared close sequence similarity with the previously
reported viruses from Pakistan (JN001862) as well as to those from
Belgium (HQ392261, HQ392204) and USA (JN258346). The
VP7 sequences of G9 strains were found 100% identical among
themselves as well as highly similar level of homology was found
with the viruses from South Africa (GQ338887), Russia
(FJ447573) and Australia (AY307090). These viruses also hold
98% similarity to previously reported G9 strains (JN001865,
JN001866) from Faisalabad city of Pakistan (unpublished data).
Likewise, the G2 viruses showed 99–100% identity among
themselves and a similar genetic closeness was found among the
G2 strains from Bangladesh (EF690778, EF690782) as well as the
already identified G2 strains from Pakistan (JN001883; unpub-
lished data).
The genetic relationships of rotavirus strains from this study
were also determined on the basis of VP4 gene. 14 viruses were
grouped among three genotypes P [4], P [6] and P [8] with the
highest prevalence of P [8] in combination with G1, G2 and G9.
The genotype P [6] was found with G1 and G9 counterparts while
P [4] was found with G2 as the most common circulating strains
during the study period with 48% prevalence. In a pattern similar
to the G-types, P [6] and P [8] strains detected from Lahore
during 2008 and 2009 revealed closest identity to already reported
viruses from Pakistan (JN001876-79 unpublished data).
Phylogenetic reconstruction revealed clustering of all rotavirus
strains from Children Hospital, Lahore with viruses (JN001862
(G1P [8]); JN001865 (G9P [8]); JN001883 (G2P [6]) previously
detected from the Faisalabad district, located in the South-West of
Lahore at a distance of 118 kilometers (Figure 2a and 2b). The
viruses classified as G1 are categorized into two separate lineages.
Lineage A contains rotavirus strains from both Lahore and
Faisalabad. Two of the strains (NIHPAK-210 and NIHPAK-417)
Rotavirus Epidemiology in Pakistan
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were distinguished as Lineage B clustering with viruses from USA
(JN258346) and Belgium (HQ392204).
Comparison of RVA-VP7 Antigenic Regions between
Pakistani and Vaccine Strains
The effectiveness of rotavirus vaccines can be determined by
analyzing the amino acid (aa) differences, in the neutralizing
epitopes of VP7 and VP4 proteins, between vaccine and the
circulating strains. We compared the VP7 aa sequences of
Pakistani viruses, constituting the antigenic epitopes with those
of the two available vaccines strains (RotaTeqTM and RotarixTM).
The VP7 protein contains three antigenic epitopes defined as 7-1a,
7-1b and 7-2 which comprise of 29 amino acid residues from
positions 87 to 291 based on rhesus Rotavirus strain numbering
(GenBank accession No. AF295303) [16]. The comparison of all
Pakistani rotavirus strains found in Lahore and vaccine strains
showed that out of total 29 amino acids, only five are conserved
(Figure 3a).
Analysis of Pakistani G1 strains showed that the 29 amino acid
residues across the three antigenic sites are highly conserved when
compared to RotarixTM G1P [8] strain while 02 differences were
found at positions 97 (D.E; Aspartic acid to Glutamic acid) and
147 (S.N; Serine to Asparagine) within the 7-1a and 7-2 regions
when compared to RotaTeqTM G1P [5] strain.
The VP7 antigenic epitopes of G2 Pakistani viruses showed 3
variations (02 substitutions within 7-1a and 01 change in 7-1b)
from the RotaTeqTM G2P [5] strain. These differences were
observed at positions 87 and 96 of 7-1a epitopes (A.T; Alanine to
Threonine and D.N; Aspartic acid to Asparagine) and 242 in 7-
1b (S.N; Serine to Asparagine) while the aa residues within the 7-
2 epitope were all conserved. When compared to RotarixTM
strain, 18 variations were noticed spanning across the three
epitope regions, predominantly in the 7-1a and 7-2 regions.
Among the G9 viruses presented in this study, the VP7 protein
was compared with RotarixTM G1 strain as well as all constituent
strains of RotaTeqTM vaccine (G1-4 with P [5] and G6P [8]).
Thirteen aa changes were found when compared to RotarixTM
strain across all three epitopes. On comparison with the
RotaTeqTM G1 strain, 14 variations were found in Pakistani
viruses. In comparison to G2 RotaTeqTM strain, 19 aminoacid
changes were noticed. Similarly, 11 variations were observed
between G3 RotaTeqTM strain and the Pakistani G9 viruses with
majority of differences found in 7-1b epitope in which all the aa
residues were changed except Glutamine at position 201. For G4
RotaTeqTM strain, 10 aa changes were found in study strains
Figure 1. Phylogenetic analysis of VP7 gene segment of the study viruses isolated in hospitalized children at Lahore. Each of the G1,
G2 and G9 genotype viruses from this study are indicated with round circle, while the previous available sequences in GenBank from Pakistan have
been given with an arrow-head. The closely matched sequences have retrieved from NCBI GenBank and included to reconstruct a phylogenetic tree
(Figure 1a). Phylogenetic analysis of VP4 gene segment of the study viruses isolated in hospitalized children at Lahore. Each of the P [4], P [6] and P [8]
genotype viruses from this study are indicated with round circle, while the previous available sequences in GenBank from Pakistan have been given
with an arrow-head. The closely matched sequences have retrieved from NCBI GenBank and included to reconstruct a phylogenetic tree (Figure 1b).
doi:10.1371/journal.pone.0067998.g001
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across the three epitope regions. When compared to G6P [8]
RotaTeqTM strain, 12 dissimilarities were noticed across the three
antigenic regions mainly within the 7-1b region.
Comparison of RVA-VP4 Antigenic Regions between
Pakistani and Vaccine Strains
The VP4 protein of rotavirus contains four antigenic regions
defined as 8-1 to 8-4 spanning between aminoacid positions 88 to
196 based on rhesus Rotavirus strain (GenBank accession No.
AY033150) [17]. The VP4 sequences of Pakistani viruses were
compared to those of vaccine strains and found significant
variations among the four regions except aminoacid residue 180
and 132 which were well conserved amongst all Pakistani and
vaccine strains (Figure 3b).
When compared to RotarixTM P [8] strain, the Pakistani P [8]
strains with G1 and G2 counterparts showed higher degree of
disparity than those with G9. Importantly, the Pakistani strains
contained 3 to 12 residues that differed from the RotaTeqTM P [8]
strain while RotarixTM strain P [8] was more variable with 7 to 13
aminoacid differences. Interestingly, all the three aminoacid
residues (87–89; NTN) of 8-4 epitope were well conserved among
all P [8] Pakistani viruses.
A high degree of variation was observed for P [4] and P [6]
strains as well. For P [4] strains, there were 13 aminoacid
differences when compared to RotarixTM while 22 to 23 residues
were different from RotaTeqTM strains. Comparison of P [6]
strains showed 17 differences with RotarixTM whereas 20
aminoacid differences were found when compared to RotaTeqTM
strains.
Discussion
Diarrhea is accountable for approx. 5% of all deaths among
children below five years of age. Viral pathogens are the most
common cause of gastroenteritis in both developing and developed
countries [18–20] especially rotaviruses, noroviruses, astroviruses
and adenoviruses [21]. Three rotavirus serogroups (A, B and C)
are known to cause gastroenteritis in humans [22]. The most
commonly associated VP7 genotypes of group-A rotavirus with
Figure 2. Number of samples collected from hospitalized children admitted with gastroenteritis during January 2008 to December
2009. Months are represented on X-axis while Y-axis indicates Number of cases. The percentages are shown on secondary axis. Total, Positive and
percentage figures are represented by black, grey and dotted line trend respectively (Figure 2a). Age wise distribution of samples collected from
hospitalized patinets presented with the complaints of gastroenteritis during January 2008 to December 2009. The total number of samples were
distributed among age-groups (given on X-axis) while number of samples are given on Y-axis (total no. shown in black and EIA psoitive samples in
grey color) with the percentages shown with data labels (Figure 2b).
doi:10.1371/journal.pone.0067998.g002
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different combinations of VP4 genetic counterparts are G1, G2,
G3, G4 and G9 [23]. However, unusual genotypes with different
G and P specifities have recently been reported from various parts
of the world [1].
Seasonality of rotavirus gastroenteritis in Pakistan has never
been determined although the cases have been detected round the
year [24]. In our study, rotavirus was found during all seasons
especially early and late calendar months. This may be attributed
to the rainy and post-monsoon season in our country and support
the previous findings that low air temperature and dry environ-
ment increase the rotavirus incidence [25]. The same pattern is
peculiar to tropical areas where rotavirus infections appear
throughout the year without any significant epidemic peaks [26].
Similar findings have been reported from Bangladesh, South Asian
regions, Bahrain and Costa Rica where rotavirus is detected all
year round with less obvious seasonality [27–30]. However, our
findings contrast those in USA, Japan, Northern Asian region,
Australia and Europe where rotavirus diarrhea peaks in winter
and is rarely identified in summer [31–35].
The higher percentage of samples positive for rotavirus was
found among the children between 12 and 17 months of age.
These findings are slightly variable than the previous study
conducted in Karachi city of Pakistan [36] where most of the
rotavirus infections were found among children less than 12
months of age. This variation might reflect a different study design
and target population i.e. our study includes the samples from
patients hospitalized with severe gastroenteritis whereas Qazi et al.
[36] studied the incidence of rotavirus associated infections in low-
income communities of Karachi.
During the last 15 years, very few reports about circulating
genotypes of rotavirus are available from Pakistan [36–38] in
which circulation of G1, G2, G4 and G9 in combination with P
[4], P [6], P [8], P [11] have been described. The current study is
focused on the detection of circulating genotypes of rotavirus
causing gastroenteritis in Lahore city of Punjab province and
provides relatively comprehensive epidemiological as well as
genetic information. Although G1 is the most common genotype
found in diarrhea or gastroenteritis cases worldwide, we found
G2P [4] as the most prevalent genotype in 48% of study samples.
Genotype G9 was found among 20% of our samples in
combinations with P [4], P [6] and P [8]. A similar increased
prevalence of G9 strains have been found in neighboring countries
including India and Bangladesh [39]. This genotype has recently
gained sufficient epidemiological concern worldwide due to its
variable vaccine response and infectivity rate [9,40]. We found
G9P [8] as the third most prevalent genotype which is consistent
Figure 3. Alignment and comparison of surface exposed amino acid motifs constituting the major epitopes of the rotavirus strains.
Antigenic regions of VP7 (Figure 3a) and VP4 (Figure 3b) proteins were aligned and compared between the Pakistani rotavirus strains and those of
the two licensed vaccines; RotarixTM and RotaTeqTM. The differences are highlighted by the shaded positions. These differences indicate a variation in
comparison either with one of the two vaccines. Antigenic regions within the VP7 are shown above as 7-1a, 7-1b and 7-2. For VP4, the antigenic
regions are indicated as 8-1, 8-2, 8-3 and 8-4.
doi:10.1371/journal.pone.0067998.g003
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with the recent findings from India [41]. 20% of our samples were
found positive for G1P [6] which has not been reported previously
from Pakistan. We did not detect any G3 and G4 genotypes in our
samples which substantiate the global scenario of their significant
decline during the recent years [41]. G1P [8] was found in only 1
sample even though it has remained the most common strain
detected globally and constitutes one of the currently recom-
mended vaccine, RotarixTM. Surprisingly, we did not find any
G12 genotype in this study which has recently emerged with
numerous reports of global spread [42,43]. We cannot speculate
the absolute absence of this genotype from our population due to
limited time period and number of samples selected for this study.
Such variation and vast genetic differences of rotavirus strains
evoke the need for continued surveillance to assess and consider
the role of strain variability in the design of new vaccine candidates
as well as to measure the impact of vaccine introduction in the
community. The continued surveillance programs and character-
ization of rotavirus strains during the post-vaccination era is
needed to monitor the emergence of ‘escape’ strains due to long-
term pressure exerted by homotypic immunity [44].
In the present study, we compared the amino acid motifs
constituting the neutralizing epitopes of VP7 and VP4 proteins
between the circulating Pakistani rotaviruses and available vaccine
strains. Multiple antigenic variations were noticed among both
VP7 and VP4 epitopes highlighting the need for detailed antigenic
mapping of prevalent rotavirus genotypes in the country.
Complete genome sequencing will therefore be required to
generate more comprehensive information on molecular epidemi-
ology and evolutionary dynamics of rotaviruses on account of its
segmented genome and the possible role of internal genes in
immunity [45]. Although the aminoacid residues within the VP7
protein of G1 strains showed higher similarities with the
RotarixTM strains, significant differences were found amongst all
four epitopes of VP4 proteins. In addition, a comparable degree of
disparities was noticed among the RotaTeqTM and the Pakistani
strains in both VP7 and VP4 proteins. Although such differences
do not change the genotype specificity of the rotavirus strain, they
may significantly influence the binding of neutralizing antibodies
and hence viral fitness through selective pressure [45]. Similar
findings have been reported from countries such as Belgium where
rotavirus immunization program was initiated in 2006 followed by
rapid massive coverage of up to 88% [46].
The vaccine introduction has significantly reduced the rotavirus
disease burden in many countries like Australia, Austria, Belgium,
Brazil, El Salvador, Nicaragua, Panama and the United States and
both vaccines have been found to carry equivalent efficacy against
G1, G3, G4 and G9 strains with P [8] specificity [47]. The
RotarixTM vaccine efficacy against G2 strains is somewhat lower
as compared to other genotypes while data pertaining to G12
strains is not available as yet [47]. In addition, the vaccine
introduction has modified the epidemiological patterns of circu-
lating strains in certain regions such as the upsurge of G3 strains in
the United States and Australia after introduction of RotaTeqTM
[48–50]. Therefore, further detailed epidemiological studies must
be planned to monitor the vaccine response during pre-and post-
vaccination periods in Pakistani Population.
The mutations in the antigenic regions of rotavirus play an
important role in the outcome of vaccine response. When
compared to the respective prototype strains, our data substan-
tiates the previous findings [51,52] that the currently circulating
G9 genotypes are different from their prototypes that were isolated
during 1980s. There are about 15 known mutations in the
antigenic regions of G9 genotype that can modify the antigenicity
of the respective region [53]. Similarly, for G1 genotypes, the
substitutions at positions 94, 97, 147 and 291 of VP7 protein are
found to play a significant role in antigenic recognition [54]. In
respect to G2 rotavirus genotypes, the substitution D96N within
the antigenic region A was found responsible for failure of G2-
specific monoclonal antibodies to react [55], but none of these
mutations were found in Pakistani strains, except for G2 strains
where D96N; Aspartic acid to Asparagine, substitution was found
amongst all viruses from Pakistan (data not shown). Jin et al
reported that most of the currently circulating G1 strains and the
RotarixTM vaccine RRV-S1 strain differ in their antigenic
properties and mutations in these antigenic sites may ultimately
cause vaccine failure [56].
Despite these variable epidemiological reports, it has been now
established that rotavirus vaccines are equally effective against vast
diversity of rotavirus genotypes by generating heterotypic immune
response. In the recent vaccine trails, both RotarixTM and
RotaTeqTM have been proven as equally effective in regions with
high child and adult mortality [57]. Multiple reviews from high
and middle income countries have reported a substantial reduction
in disease burden within a few years of vaccine implementation
through decreased magnitude of rotavirus associated diarrhea and
deaths [58,59]. For instance, studies in Mexico and Brazil reported
a reduction in diarrhea related deaths in infants and young
children after the introduction of rotavirus vaccine [60,61].
RotarixTM efficacy has been evaluated in a large clinical trial of
more than 63,000 infants from 11 Latin American countries and
Finland, and was found to be safe and highly immunogenic
[62,63]. Similarly, in a randomized, double-blind, placebo-
controlled study conducted in 6 European countries, RotarixTM
was observed to be highly immunogenic [64]. RotaTeqTM efficacy
has also been evaluated in two phase-III trials among healthy
infants, including a large clinical trial of more than 70,000 infants
enrolled primarily in the United States and Finland, and found to
be highly immunogenic [65,66]. As a final point, in April 2009, the
World Health Organization’s (WHO) Strategic Advisory Group of
Experts (SAGE) on immunization recommended the inclusion of
rotavirus vaccination of infants into all national immunization
programs, with a stronger recommendation for countries where
‘‘diarrheal deaths account for $10% of mortality among children
aged ,5 years’’ [67]. In addition, it has been emphasized that the
introduction of rotavirus vaccine should be accompanied by
measures to ensure high vaccination and timely administration of
each vaccine dose.
Conclusion
Our present findings conclude that the rotavirus genotypes
circulating in different geographical areas of Pakistan are quite
variable and large scale studies must be conducted to calculate the
burden of disease as well as the epidemiological understanding of
contributing viral genotypes. Similar diversity of prevalent
rotavirus strains within the Indian subcontinent including Pakistan
has been reported by Miles et al., [41]. The annual birth rate in
Pakistan is approximately five million; the right rotavirus vaccine
would be greatly helpful to protect newborns from this serious
disease and its associated mortality. Although our report does not
describe a thorough representation of the prevailing genotypes
throughout the country, but it provides significant information for
the health policy makers to review and implement informed
immunization policy in the country.
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